Wip1 over-expression correlated with TP53/p14(ARF) pathway disruption in human astrocytomas
Peng Wang1, Jing Rao, Haifeng Yang
1Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China.
Journal of Surgical Oncology
|June 23, 2011
Summary
Wip1 is over-expressed in astrocytomas lacking TP53 or p14(ARF) alterations, suggesting it may inhibit this critical tumor suppressor pathway. This finding is crucial for understanding astrocytoma progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Wip1 (Wild-type p53-induced phosphatase 1) is a negative regulator of p53.
- p53 pathway alterations are common in cancer, including astrocytomas.
- Understanding Wip1's role in astrocytoma is key to deciphering cancer progression mechanisms.
Purpose of the Study:
- To investigate the correlation between Wip1 expression and TP53/p14(ARF) pathway disruption in astrocytomas.
- To determine if Wip1 over-expression is associated with specific alterations in the TP53/p14(ARF) pathway.
Main Methods:
- Analysis of TP53 mutations, p14(ARF) expression, and Wip1 expression in 52 astrocytoma samples.
- TP53 gene sequencing (exons 5-8) and p14(ARF) promoter methylation analysis (MSP).
- Wip1 expression quantified by real-time PCR, Western blot, and immunohistochemistry.
Main Results:
- TP53/p14(ARF) pathway disruption occurred in 57.7% of astrocytomas.
- Wip1 mRNA over-expression was observed in 50% of cases with intact TP53 and p14(ARF) pathways, compared to 3.3% with wild-type TP53 and p14(ARF).
- Higher Wip1 levels correlated with TP53 mutations but not with p14(ARF) expression levels or promoter hypermethylation.
Conclusions:
- Wip1 is selectively over-expressed in astrocytomas with intact TP53 and p14(ARF) pathways.
- Wip1 over-expression may play a role in inhibiting the TP53/p14(ARF) pathway in astrocytomas.
- Further research is warranted to elucidate Wip1's precise function in astrocytoma pathogenesis.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
02:54Canonical Wnt Signaling Pathway
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...